CAMBRIDGE, Mass., April 19, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today the appointment of Sol J. Barer, Ph.D., Chairman of Celgene Corporation, to its Board of Directors, effective May 1, 2011. Dr. Barer will also serve as Chair of the Compensation Committee.
